ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

ferric carboxymaltose

Also written as “Ferric Carboxymaltose (FCM)”, “Ferric carboxymaltose” and “Injectafer”.

Its studies are mostly in Anemia, Iron-Deficiency · Anemia · Iron Deficiencies · Restless Legs Syndrome · Heart Failure, led by 4 companies.

Drug pageFerric carboxymaltose: every studyAll 158 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Sep 23, 201346 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Daiichi Sankyoits history only280 open or runningphase 4since Sep 23, 2013Apr 20, 2006none ahead
CSL140 open or runningphase 4since Mar 29, 2010Aug 24, 2007none ahead
Sichuan Huiyu Pharmaceuticalits history only31 open or runningphase 1since Sep 27, 2023Sep 27, 2023none ahead
Novartisits history only10 open or runningphase 1since Dec 5, 2017Dec 5, 2017none ahead

Also a collaborator on its studies: Suzhou Guochen Biotechnology, Boji Medical Technology, ClinStar, Cytel, Tigermed Consulting, Pierrel Research Europe, ICON Clinical Research, Parexel and SGS.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of CSL only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 24, 2007First study: phase 3 study in Iron DeficienciesFirst studyNCT00520780 · 456 enrolled · Argentina, Germany, Greece and more
  2. Dec 16, 20082 phase 3 studiesNCT00810030, NCT00810004
  3. Jan 7, 2009Phase 3 study in Iron DeficienciesNCT00821717 · 35 enrolled · Denmark, France, Germany and more
  4. Apr 15, 2009Phase 2 study in ThrombocytosisNCT00882414 · 26 enrolled · Austria
  5. Oct 12, 2009Phase 3 study in Anemia, Iron-DeficiencyNCT00994318 · 626 enrolled · United States, Australia, Austria and more
  6. Mar 29, 2010Phase 4 study in Anemia, Iron-DeficiencyNCT01100879 · 3 enrolled · France, Greece
  7. Mar 30, 2010Phase 3 study in Anemia, Iron-DeficiencyNCT01101399 · 19 enrolled · Germany, Sweden
  8. Apr 22, 2010Phase 4 study in Iron DeficienciesNCT01110356 · 294 enrolled · Austria
  9. May 25, 2010Phase 3 study in AnemiaNCT01131624 · 252 enrolled · Australia, Germany, Sweden and more
  10. Jul 12, 2011Phase 3 study in Iron DeficienciesNCT01394562 · 174 enrolled · Netherlands
  11. Oct 13, 2011Phase 4 study in Iron DeficienciesNCT01453608 · 304 enrolled · Poland, Russian Federation
  12. Oct 14, 2016Phase 4 study in Iron DeficienciesNCT02937454 · 1,132 enrolled · Argentina, Brazil, Croatia and more
  13. Jun 22, 2018Phase 3 study in Anemia, Iron-DeficiencyNCT03591406 · 371 enrolled · China

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 14 CSL leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT03591406Anemia, Iron-Deficiency · China3CompletedFeb 25, 2019371
NCT02937454Iron Deficiencies · Argentina, Brazil, Croatia and more4CompletedJul 21, 20201,132
NCT01453608Iron Deficiencies · Poland, Russian Federation4CompletedFeb 2014304
NCT01394562Iron Deficiencies · Netherlands3CompletedMay 2016174
NCT01131624Anemia · Australia, Germany, Sweden and more3CompletedMay 2014252
NCT01110356Iron Deficiencies · Austria4CompletedOct 2011294
NCT01101399Anemia, Iron-Deficiency · Germany, Sweden3CompletedNov 201219
NCT01100879Anemia, Iron-Deficiency · France, Greece4TerminatedJul 20113
NCT00994318Anemia, Iron-Deficiency · United States, Australia, Austria and more3CompletedFeb 2013626
NCT00882414Thrombocytosis · Austria2TerminatedJan 201026
NCT00821717Iron Deficiencies · Denmark, France, Germany and more3TerminatedOct 200935
NCT00810030Inflammatory Bowel Diseases · Austria3CompletedDec 2009484
NCT00810004Iron Deficiencies · Russian Federation3CompletedOct 2010245
NCT00520780Iron Deficiencies · Argentina, Germany, Greece and more3CompletedJul 2009456

How it is read

Names in the registry

  • “Ferric Carboxymaltose (FCM)”, 13 entries
  • “Ferric carboxymaltose”, 8 entries
  • “Injectafer”, 5 entries
  • “Ferric Carboxymaltose”, 5 entries
  • “Ferric Carboxymaltose Injection”, 3 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.